Your browser doesn't support javascript.
loading
Effects of Dexamethasone on Satellite Cells and Tissue Engineered Skeletal Muscle Units.
Syverud, Brian C; VanDusen, Keith W; Larkin, Lisa M.
Afiliación
  • Syverud BC; 1 Department of Biomedical Engineering, University of Michigan , Ann Arbor, Michigan.
  • VanDusen KW; 2 Department of Molecular and Integrated Physiology, University of Michigan , Ann Arbor, Michigan.
  • Larkin LM; 1 Department of Biomedical Engineering, University of Michigan , Ann Arbor, Michigan.
Tissue Eng Part A ; 22(5-6): 480-9, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26790477
ABSTRACT
Tissue engineered skeletal muscle has potential for application as a graft source for repairing soft tissue injuries, a model for testing pharmaceuticals, and a biomechanical actuator system for soft robots. However, engineered muscle to date has not produced forces comparable to native muscle, limiting its potential for repair and for use as an in vitro model for pharmaceutical testing. In this study, we examined the trophic effects of dexamethasone (DEX), a glucocorticoid that stimulates myoblast differentiation and fusion into myotubes, on our tissue engineered three-dimensional skeletal muscle units (SMUs). Using our established SMU fabrication protocol, muscle isolates were cultured with three experimental DEX concentrations (5, 10, and 25 nM) and compared to untreated controls. Following seeding onto a laminin-coated Sylgard substrate, the administration of DEX was initiated on day 0 or day 6 in growth medium or on day 9 after the switch to differentiation medium and was sustained until the completion of SMU fabrication. During this process, total cell proliferation was measured with a BrdU assay, and myogenesis and structural advancement of muscle cells were observed through immunostaining for MyoD, myogenin, desmin, and α-actinin. After SMU formation, isometric tetanic force production was measured to quantify function. The histological and functional assessment of the SMU showed that the administration of 10 nM DEX beginning on either day 0 or day 6 yielded optimal SMUs. These optimized SMUs exhibited formation of advanced sarcomeric structure and significant increases in myotube diameter and myotube fusion index, compared with untreated controls. Additionally, the optimized SMUs matured functionally, as indicated by a fivefold rise in force production. In conclusion, we have demonstrated that the addition of DEX to our process of engineering skeletal muscle tissue improves myogenesis, advances muscle structure, and increases force production in the resulting SMUs.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dexametasona / Ingeniería de Tejidos / Células Satélite del Músculo Esquelético Límite: Animals Idioma: En Revista: Tissue Eng Part A Asunto de la revista: BIOTECNOLOGIA / HISTOLOGIA Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dexametasona / Ingeniería de Tejidos / Células Satélite del Músculo Esquelético Límite: Animals Idioma: En Revista: Tissue Eng Part A Asunto de la revista: BIOTECNOLOGIA / HISTOLOGIA Año: 2016 Tipo del documento: Article